Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126703362 | 12670336 | 2 | F | 201509 | 20150928 | 20160822 | 20160928 | PER | US-SUN PHARMACEUTICAL INDUSTRIES LTD-2015US-104805 | RANBAXY | 0.00 | F | Y | 0.00000 | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126703362 | 12670336 | 1 | PS | LORATADINE. | LORATADINE | 1 | Unknown | 1 DF, QD | U | 169056 | 76134 | 1 | DF | TABLET | |||||
| 126703362 | 12670336 | 2 | SS | LORATADINE. | LORATADINE | 1 | U | 76134 | TABLET | ||||||||||
| 126703362 | 12670336 | 3 | SS | MELOXICAM. | MELOXICAM | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126703362 | 12670336 | 1 | Hypersensitivity |
| 126703362 | 12670336 | 2 | Sinusitis |
| 126703362 | 12670336 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126703362 | 12670336 | Balance disorder | |
| 126703362 | 12670336 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126703362 | 12670336 | 1 | 201509 | 0 |